RPS: Brexit poses counterfeit medicines risk as FMD benefits lost

The government must put “robust plans” in place to ensure counterfeit medicines don’t enter the supply chain as FMD ceases to apply across the UK post Brexit, the RPS has said.

pharmacy%20scanner.jpg
RPS: UK will “cease to benefit” from FMD once the Brexit transition period ends

Latest from News

More from Politics